Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 61.00
Bid: 60.00
Ask: 62.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.333%)
Open: 61.00
High: 61.00
Low: 61.00
Prev. Close: 61.00
PCIP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options

5 Nov 2013 17:57

RNS Number : 2908S
IPPlus PLC
05 November 2013
 

IPPlus plc

(the "Company" or the "Group")

 

Grant of Performance Related Options

 

IPPLUS PLC announces that on 4 November 2013 the Company granted performance related options over a total of 600,000 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") (the "2013-2016 Awards") in accordance with the recommendations of the Company's Remuneration Committee.

 

The 2013-2016 Awards relate to a performance period beginning on 1 July 2013 and ending on 30 June 2016 and, assuming certain performance targets are met, will ordinarily vest on 13 September 2016 (or such later date as the Company publishes its annual results for the year ending 30 June 2016).

 

The vesting proportion of options granted under the 2013-2016 Awards is subject to the Group's consolidated profit before tax for the financial year ending 30 June 2016 reaching or exceeding certain specified thresholds. These performance arrangements have been designed to align management and employee interests with those of the Company's shareholders.

 

As part of the 2013-2016 Awards, options were granted to the following Executive Directors:

 

Director

Position

Number of options over Ordinary Shares granted

Exercise Price

 

William Catchpole

 

CEO

 

100,000

 

1p

 

R. Stuart Gordon

 

CFO

 

100,000

 

1p

 

Geoffrey Forsyth

 

CTO

 

100,000

 

1p

 

The performance conditions of the 2013-2016 Awards have been specified by the Remuneration Committee and are subject to claw back provisions in certain circumstances.

 

Following the 2013-2016 Awards, the above Directors are interested in the following Ordinary Shares and options over Ordinary Shares in the Company:

 

Director

Number of Ordinary Shares held

Percentage of voting rights in the Company

Total options over Ordinary Shares held

Exercise price

Expiry date of options

 

William Catchpole

 

2,560,870

 

8.12%

 

101,508

100,000

100,000

 

1p

1p

1p

 

28 June 2022

26 November 2022

4 November 2023

 

R. Stuart Gordon

 

951,433

 

3.02%

 

101,508

100,000

100,000

 

1p

1p

1p

 

28 June 2022

26 November 2022

4 November 2023

 

Geoffrey Forsyth

 

991,456

 

3.14%

 

101,508

100,000

100,000

 

1p

1p

1p

 

28 June 2022

26 November 2022

4 November 2023

 

The Company's issued share capital as at 5 November 2013 consists of 31,721,178 Ordinary Shares. The Company holds 167,229 Ordinary Shares in Treasury. Therefore, the total number of voting rights in the Company is 31,553,949.

 

The Company also has a total of 2,484,425 options over Ordinary Shares outstanding including the amounts held by the Directors above.

 

 

For further details, please contact:

 

IPPlus plc

William Catchpole - Chief Executive Officer

R Stuart Gordon - Chief Financial Officer

 

+44 844 544 6800

N+1 Singer (NOMAD & Broker)

Aubrey Powell / Alex Wright

+44 20 7496 3000

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBRBDBSUGBGXU
Date   Source Headline
17th Apr 20245:45 pmRNSHolding(s) in Company
8th Apr 202410:28 amRNSIssue of Equity & TVR
5th Apr 20247:00 amRNSIssue of Options & Director Share Purchases
4th Apr 202410:24 amRNSIssue of Equity & TVR
28th Mar 20246:15 pmRNSHolding(s) in Company
27th Mar 20247:00 amRNSExercise of Options, Director/PCA Dealings & TVR
26th Mar 202410:57 amRNSPDMR Issue of Options
12th Mar 202412:55 pmRNSResult of Oversubscribed Placing & TVR
12th Mar 20247:00 amRNSProposed Placing to raise up to £3.5m
27th Feb 20247:00 amRNSInterim Results, Board Change & Presentations
20th Feb 20247:00 amRNSNotice of Results, Analyst & Investor Presentation
6th Feb 20247:00 amRNSTrading Update & Notice of Results
26th Jan 202412:50 pmRNSUK Patent Case Update
22nd Jan 20244:59 pmRNSHolding(s) in Company
15th Jan 202412:20 pmRNSIssue of Equity
20th Dec 20237:00 amRNSSuccessful Completion of Form of Order Hearing
19th Dec 20237:00 amRNSUK Court Hearing
12th Dec 20231:40 pmRNSResult of AGM
12th Dec 20237:00 amRNSAGM Statement
24th Nov 202310:45 amRNSAnnual Financial Report & Notice of AGM
13th Nov 20237:00 amRNSNew strategic reseller partnership with Zoom
9th Nov 20237:00 amRNSFinal Results, Analyst Briefing & Investor Pres
6th Nov 20237:00 amRNSNotice of Results Analyst Briefing & Investor Pres
5th Oct 202311:49 amRNSIssue of Equity
4th Oct 20235:13 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSDetail on Patent Case Outcome & Trading Update
25th Sep 20235:29 pmRNSTotal Victory for PCI Pal in UK High Court
4th Sep 20237:00 amRNSHolding(s) in Company
26th Jun 202311:33 amRNSHolding(s) in Company
7th Jun 20237:00 amRNSBreach of confidentiality agreement by Sycurio Ltd
30th May 20237:00 amRNSDirector/PDMR Share Purchase
25th May 202311:08 amRNSDirector/PDMR Share Purchase
24th May 20237:00 amRNSTrading and Patent Case Updates
14th Mar 20237:00 amRNSInterim Results, Analyst Briefing & Investor Pres
13th Mar 20237:49 amRNSSVB Update
28th Feb 20237:00 amRNSNotice of Results, Analyst Call & Investor Pres
2nd Feb 20237:00 amRNSTrading Update & Notice of Results
27th Oct 202212:32 pmRNSResult of AGM
27th Oct 20227:00 amRNSAGM Statement
20th Oct 20227:00 amRNSPDMR Shareholding
7th Oct 20227:00 amRNSDirector/PDMR Issue of Options
6th Oct 20223:13 pmRNSDirector/PDMR share purchase
4th Oct 202210:37 amRNSAnnual Financial Report & Notice of AGM
22nd Sep 20227:00 amRNSPCI Pal launches open banking payments product
6th Sep 20227:00 amRNSFinal Results, Analyst Briefing & Investor Pres
16th Aug 20227:00 amRNSNotice of Results Analyst Briefing & Investor Pres
27th Jul 20227:00 amRNSTrading Update & Notice of Results
1st Jul 20227:00 amRNSDirectorate Change
30th Jun 20221:56 pmRNSIssue of Equity
28th Jun 20227:00 amRNSUpdate on Patent Infringement Claims

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.